rs139251660
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_018723.4(RBFOX1):c.290C>A(p.Pro97Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000204 in 1,613,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P97A) has been classified as Uncertain significance.
Frequency
Consequence
NM_018723.4 missense
Scores
Clinical Significance
Conservation
Publications
- epilepsyInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- neurodevelopmental disorderInheritance: AD Classification: LIMITED Submitted by: G2P
- autism susceptibility 1Inheritance: Unknown Classification: LIMITED Submitted by: Laboratory for Molecular Medicine
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_018723.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RBFOX1 | NM_018723.4 | MANE Select | c.290C>A | p.Pro97Gln | missense | Exon 6 of 16 | NP_061193.2 | ||
| RBFOX1 | NM_145893.3 | MANE Plus Clinical | c.350C>A | p.Pro117Gln | missense | Exon 3 of 14 | NP_665900.1 | ||
| RBFOX1 | NM_001415887.1 | c.887C>A | p.Pro296Gln | missense | Exon 9 of 20 | NP_001402816.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RBFOX1 | ENST00000550418.6 | TSL:1 MANE Select | c.290C>A | p.Pro97Gln | missense | Exon 6 of 16 | ENSP00000450031.1 | ||
| RBFOX1 | ENST00000355637.9 | TSL:1 MANE Plus Clinical | c.350C>A | p.Pro117Gln | missense | Exon 3 of 14 | ENSP00000347855.4 | ||
| RBFOX1 | ENST00000311745.9 | TSL:1 | c.350C>A | p.Pro117Gln | missense | Exon 3 of 13 | ENSP00000309117.5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152104Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000399 AC: 1AN: 250914 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461780Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727192 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152104Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74310 show subpopulations
ClinVar
Submissions by phenotype
Idiopathic generalized epilepsy Uncertain:1
This sequence change replaces proline, which is neutral and non-polar, with glutamine, which is neutral and polar, at codon 117 of the RBFOX1 protein (p.Pro117Gln). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with RBFOX1-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RBFOX1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at